Published : 24 February, 2026
The coverages include the successful conclusion of FESTOMICS – 2 by RGCIRC, a two-day academic programme centred on “Precision Through Omics,” which brought together leading experts in pathology, molecular diagnostics, oncology and translational research to discuss the expanding role of omics-based technologies in cancer diagnosis and treatment. As highlighted in the coverage, Dr. (Col. Retd.) Anurag Mehta, Principal Director, Laboratory Services & Transfusion Medicine at RGCIRC and Organising Chairman of FESTOMICS – 2, emphasised that molecular diagnostics are now an integral part of routine oncology practice and that the objective of the conference is to bridge the gap between complex molecular data and meaningful clinical decision-making, ensuring that advancements in genomics and precision diagnostics translate into evidence-based, individualised patient care.
RGCIRC, Niti Bagh
